Antireflux Endoluminal Therapies: Past and Present

The basic principle of antireflux procedures employing endoscopic intervention aims to create a mechanical barrier to prevent primary pathophysiology in gastroesophageal reflux disease (GERD). We review, highlight, and discuss the past and present status of endoluminal therapy. Currently, there are...

Full description

Bibliographic Details
Main Authors: Kuo Chao Yew, Seng-Kee Chuah
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2013/481417
id doaj-20dc7996a74249f9802cb919026b6793
record_format Article
spelling doaj-20dc7996a74249f9802cb919026b67932020-11-24T21:54:04ZengHindawi LimitedGastroenterology Research and Practice1687-61211687-630X2013-01-01201310.1155/2013/481417481417Antireflux Endoluminal Therapies: Past and PresentKuo Chao Yew0Seng-Kee Chuah1Department of Gastroenterology and Hepatology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, 308433, SingaporeDivision of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 123 Ta-Pei Road, Niao-Sung Hsiang, Kaohsiung 833, TaiwanThe basic principle of antireflux procedures employing endoscopic intervention aims to create a mechanical barrier to prevent primary pathophysiology in gastroesophageal reflux disease (GERD). We review, highlight, and discuss the past and present status of endoluminal therapy. Currently, there are 3 commonly employed anti-reflux endoluminal procedures: fundoplication or suturing techniques (EndoCinch, NDO, and EsophyX), intramural injection or implant techniques (enhancing lower esophageal sphincter (LES) volume and/or strengthening compliance of the LES-Enteryx and Gatekeeper), and radiofrequency ablation of LES and cardia. EndoCinch plication requires further study and modification of technique before it can be recommended because of durability issues. Esophynx, the transoral incisionless fundoplication, may reduce hiatal hernias and increase LES length. Preliminary studies have shown promising reduction in symptoms and medication use but evidence concerning safety and long-term durability is still pending. The safety issue with injection technique is the main concern as evident from the incidences of implant withdrawals after reported major adverse events. Future research with cautious monitoring is required before any new implant material can be recommended for commercial application. Radiofrequency ablation therapy is regaining popularity in treating refractory symptoms despite PPI use due to improved efficacy, durability, and safety after years of refinement of protocol.http://dx.doi.org/10.1155/2013/481417
collection DOAJ
language English
format Article
sources DOAJ
author Kuo Chao Yew
Seng-Kee Chuah
spellingShingle Kuo Chao Yew
Seng-Kee Chuah
Antireflux Endoluminal Therapies: Past and Present
Gastroenterology Research and Practice
author_facet Kuo Chao Yew
Seng-Kee Chuah
author_sort Kuo Chao Yew
title Antireflux Endoluminal Therapies: Past and Present
title_short Antireflux Endoluminal Therapies: Past and Present
title_full Antireflux Endoluminal Therapies: Past and Present
title_fullStr Antireflux Endoluminal Therapies: Past and Present
title_full_unstemmed Antireflux Endoluminal Therapies: Past and Present
title_sort antireflux endoluminal therapies: past and present
publisher Hindawi Limited
series Gastroenterology Research and Practice
issn 1687-6121
1687-630X
publishDate 2013-01-01
description The basic principle of antireflux procedures employing endoscopic intervention aims to create a mechanical barrier to prevent primary pathophysiology in gastroesophageal reflux disease (GERD). We review, highlight, and discuss the past and present status of endoluminal therapy. Currently, there are 3 commonly employed anti-reflux endoluminal procedures: fundoplication or suturing techniques (EndoCinch, NDO, and EsophyX), intramural injection or implant techniques (enhancing lower esophageal sphincter (LES) volume and/or strengthening compliance of the LES-Enteryx and Gatekeeper), and radiofrequency ablation of LES and cardia. EndoCinch plication requires further study and modification of technique before it can be recommended because of durability issues. Esophynx, the transoral incisionless fundoplication, may reduce hiatal hernias and increase LES length. Preliminary studies have shown promising reduction in symptoms and medication use but evidence concerning safety and long-term durability is still pending. The safety issue with injection technique is the main concern as evident from the incidences of implant withdrawals after reported major adverse events. Future research with cautious monitoring is required before any new implant material can be recommended for commercial application. Radiofrequency ablation therapy is regaining popularity in treating refractory symptoms despite PPI use due to improved efficacy, durability, and safety after years of refinement of protocol.
url http://dx.doi.org/10.1155/2013/481417
work_keys_str_mv AT kuochaoyew antirefluxendoluminaltherapiespastandpresent
AT sengkeechuah antirefluxendoluminaltherapiespastandpresent
_version_ 1725869225590915072